16:54 EST Xeris Biopharma (XERS) files $250M mixed securities shelf
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XERS:
- Xeris Biopharma reports Q4 EPS (3c), consensus (2c)
- Xeris Biopharma sees FY25 revenue $255M-$275M, consensus $239.77M
- XERS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Xeris Pharmaceuticals Appoints New Chief Medical Officer
- Xeris Biopharma CEO Ken Johnson to retire, Anh Nguyen to succeed